Free Trial

AstraZeneca (AZN) Dividend Yield, Date & History

AstraZeneca logo
$65.35 +0.91 (+1.41%)
(As of 12/20/2024 05:51 PM ET)

AstraZeneca Dividend Summary

Dividend Yield
1.50%
Annual Dividend
$0.98
Recent
Dividend Payment
Sep. 9
Annualized 3-Year
Dividend Growth
1.18%
Dividend Payout Ratio
46.89%

AstraZeneca (AZN) pays an annual dividend of $0.98 per share, with a dividend yield of 1.50%. The next annually payment of $0.49 per share was paid on Monday, September 9, to investors who owned the stock before the ex-dividend date of Friday, August 9. The company currently pays out 46.89% of its earnings and 18.51% of its cash flow as dividends.

Get Dividend Stock Ideas Daily

Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news.

Sign Up
Skip Charts & View Dividend History

AZN Dividend Payments by Quarter

The chart below displays up to four years of AstraZeneca's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.

AZN Dividend Yield Over Time

The chart below tracks AstraZeneca's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.

AstraZeneca vs. The Competition

Compare AstraZeneca's annual dividend, yield, and 3-year growth rate with averages for Medical and NASDAQ companies to evaluate its performance against the market.

TypeAstraZenecaMedical CompaniesNASDAQ Companies
Annual Dividend$0.98$0.06$1.31
Dividend Yield1.50%5.09%4.23%
Annualized 3-Year Dividend Growth1.18%16.19%14.22%

AstraZeneca Dividend Payout Ratio

Dividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.

TypePayout Ratio
Based on Trailing 12 Months of Earnings46.89%
Based on This Year's Estimate23.84%
Based on Next Year's Estimate20.76%
Based on Cashflow18.51%

AstraZeneca Dividend History by Quarter

AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date
7/25/2024Semi-Annual$0.49-$0.4750
49.22%
1.8%8/9/20248/9/20249/9/2024
2/8/2024Semi-Annual$0.9650+$0.50
107.53%
2.3%2/22/20242/23/20243/25/2024
7/28/2023semi-annual$0.4650-$0.52
52.79%
2%8/10/20238/11/20239/11/2023
2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)

Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.

Click here to see Dan's full warning to the public.
2/9/2023semi-annual$0.9850+$0.52
111.83%
2%2/23/20232/24/20233/27/2023

This table shows AstraZeneca's annuallydividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time.

AstraZeneca Dividend - Frequently Asked Questions

The current dividend yield for AstraZeneca is 1.50%. Learn more on AZN's dividend yield history.

The annual dividend for AZN shares is $0.98. Learn more on AZN's annual dividend history.

AstraZeneca pays annually dividends to shareholders.

AstraZeneca's most recent annually dividend payment of $0.49 per share was made to shareholders on Monday, September 9, 2024.

AstraZeneca's most recent ex-dividend date was Friday, August 9, 2024.

Over the past three years, the company's dividend has grown by an average of 1.18% per year.

The most recent change in the company's dividend was a decrease of $0.4750 on Thursday, July 25, 2024.

The dividend payout ratio for AZN is:
  • 46.89% based on the trailing year of earnings
  • 23.84% based on this year's estimates
  • 20.76% based on next year's estimates
  • 18.51% based on cash flow

AstraZeneca's dividend yield of 1.52% is lower than the average Medical company that issues a dividend. AstraZeneca's dividend payout ratio of 46.89% is at a healthy, sustainable level, below 75% of its earnings.

Looking at the stock as a whole, market analysts rate AstraZeneca stock as a Moderate Buy, forecasting growth opportunities and potential value appreciation.


This page (NASDAQ:AZN) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners